Effect of Metabolic Syndrome on the Outcomes of Hospitalized Heart Failure Patients and Reduced Ejection Fraction

Shaho  Eskandar; Abdulkareem AbdulWahab  Al Othman

doi:10.56056/amj.2025.369

Authors

Shaho Eskandar MBCh.B., candidate at KHCMS (Internal Medicine).Department of Medicine,Hawler teaching hospital, Erbil, Kurdistan Region, Iraq,
Abdulkareem AbdulWahab Al Othman MBChB, FICMS, FRCP(Glasg.) Professor of Medicine,Department of Medicine,College of Medicine,Hawler Medical University. Erbil, Kurdistan Region, Iraq

DOI:

https://doi.org/10.56056/amj.2025.369

Keywords:

Heart Failure, In-hospital outcomes, Metabolic syndrome, Reduced Ejection Fraction

Abstract

Background and Objectives: Heart disease and metabolic syndrome are two of the most common health problems in the world. In this study we aimed to assess the relationship between the presence of metabolic syndrome and in-hospital cardiogenic shock, mortality and severety of left ventricular systolic dysfunction in heart failure patients with reduced ejection fraction.

Methods: Utilizing a cross-sectional design, with a duration of 8 months, from March to October 2023, at Howler Teaching Hospital. We enrolled 104 adult patients aged 18 and above, both genders, 54 men and 50 women patients were categorized based on metabolic syndrome presence. All had clinical and echocardiographic heart failure with reduced ejection fraction, and metabolic syndrome was defined per International Diabetes Federation criteria.

Results: Metabolic syndrome reported in 56 (53.8%) of heart failure patients with reduced ejection fraction. Cardiogenic shock was more common in individuals with metabolic syndrome 13 (23.2%) versus non metabolic syndrome 2 (4.2%), P< 0.006. High incidence of severe left ventricular systolic dysfunction reported among patients with metabolic syndrome 47 (88.7%) versus non metabolic syndrome 9 (17.6%), P <0.01.

Conclusions: Metabolic syndrome in heart failure with reduced ejection fraction increases the risk of poor outcomes; severe left ventricle systolic dysfunction and cardiogenic Shock.

Downloads

Download data is not yet available.

References

1. Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7.

2. Savarese G, Stolfo D, Sinagra G, Lund LH. Heart failure with mid-range or mildly reduced ejection fraction. Nat Rev Cardiol. 2022;19(2):16–100.

3. Huang ZM, Chen WR, Su QW, Huang ZW. Prognostic impact of metabolic syndrome in patients with heart failure: a meta-analysis of observational studies. Front Cardiovasc Med. 2021; 8:704446.

4. Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011 May; 9:48.

5. Al-Rubeaan K, Bawazeer N, Al Farsi Y, Youssef AM, Al-Yahya AA, AlQumaidi H, et al. Prevalence of metabolic syndrome in Saudi Arabia - a cross-sectional study. BMC Endocr Disord. 2018;18(1):16. Available from: https://doi.org/10.1186/s12902-018-0244-4/

6. Bader KA, Maatook MA, Zaboon IA. Metabolic syndrome distribution based on diagnostic criteria and family history among adults in Al-Basra, Iraq. J Public Health Africa. 2023;14(8):66–71.

7. Ingelsson E, Ärnlöv J, Lind L, Sundström J. Metabolic syndrome and risk for heart failure in middle-aged men. Heart. 2006;92(10):13–1409.

8. Ashrafian H, Frenneaux MP, Opie LH. Metabolic mechanisms in heart failure. Circulation. 2007;116(4):434–48.

9. Lee HY. Heart Failure and Diabetes Mellitus: Dangerous Liaisons. Int J Hear Fail. 2022 Oct;4(4):163–74.

10. Yang CD, Pan WQ, Feng S, Quan JW, Chen JW, Shu XY, et al. Insulin Resistance Is Associated with Heart Failure with Recovered Ejection Fraction in Patients without Diabetes. J Am Heart Assoc. 2022;11(19): e026184.

11. Douglas PS, Carabello BA, Lang RM, Lopez L, Pellikka PA, Picard MH, et al. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards and the American Society of Echocardiography. J Am Coll Cardiol. 2019 Jul;74(3):69–403.

12. Lam CSP, Solomon SD. Classification of heart failure according to ejection fraction: JACC review topic of the week. J Am Coll Cardiol. 2021;77(25):25–3217.

13. Perrone-Filardi P, Paolillo S, Costanzo P, Savarese G, Trimarco B, Bonow RO. The role of metabolic syndrome in heart failure. Eur Heart J. 2015;36(39):4–2630.

14.Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al . 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37:2129–2200.

15. Guembe MJ, Fernandez-Lazaro CI, Sayon-Orea C, Toledo E, Moreno-Iribas C. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Cardiovasc Diabetol. 2020;19(1):1–14.

16. Zhou Y, Fu L, Sun J, Zhu Z, Xing Z, Zhou S, et al. Association between metabolic syndrome and an increased risk of hospitalization for heart failure in population of HFpEF. Front Cardiovasc Med. 2021; 8:698117.

17. Li X, Zhai Y, Zhao J, He H, Li Y, Liu Y, et al. Impact of metabolic syndrome and it’s components on prognosis in patients with cardiovascular diseases: a meta-analysis. Front Cardiovasc Med. 2021; 8:704145.

18. Fanta K, Daba FB, Asefa ET, Chelkeba L, Melaku T. Prevalence and Impact of Metabolic Syndrome on Short-Term Prognosis in Patients with Acute Coronary Syndrome: Prospective Cohort Study. Diabetes Metab Syndr Obes. 2021; 14:3253–62.